Gender differences in ventricular arrhythmia recurrence in patients with coronary artery disease and implantable cardioverter-defibrillators
- PMID: 15193696
- DOI: 10.1016/j.jacc.2004.03.031
Gender differences in ventricular arrhythmia recurrence in patients with coronary artery disease and implantable cardioverter-defibrillators
Abstract
Objectives: We sought to determine whether men and women with coronary artery disease (CAD) and implantable cardioverter-defibrillators (ICDs) differ in frequency of arrhythmia recurrence and whether gender differences are independent of clinical, electrocardiographic, and electrophysiologic characteristics.
Background: Epidemiologic studies show that women have a lower rate of sudden cardiac death (SCD) than men, even among patients with CAD. Whether this is due to differing susceptibilities to ischemia or to arrhythmia is unknown.
Methods: The clinical records and ICD data disks of 340 men and 59 women with CAD who received an ICD between June 1990 and June 2000 were reviewed. Ventricular tachycardia (VT) or ventricular fibrillation (VF) recurrences were compared between genders and relationship with other factors was analyzed.
Results: Sustained VT/VF occurred in 52% of men and 34% of women (p < 0.01). Men experienced more total VT/VF events (p < 0.01), more shock-treated VT/VF events (p < 0.03), more electrical storms (p < 0.001), and had VT/VF on more days in follow-up (p < 0.01). Gender differences were independent of measured clinical, electrocardiographic, and electrophysiologic factors. In stratified analyses, the gender differences in VT/VF recurrence were greatest in patients presenting with sustained monomorphic VT and those with inducible VT at electrophysiology study.
Conclusions: Women were less likely to experience VT/VF, and had fewer VT/VF episodes, than men. These findings were strongest in patients with evidence of a stable anatomic VT circuit: those with clinical or electrophysiologically induced VT. This study suggests that differing susceptibility to arrhythmia triggering may underlie the known differences in SCD rates between men and women.
Similar articles
-
Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients.J Am Coll Cardiol. 2006 Jan 3;47(1):98-107. doi: 10.1016/j.jacc.2005.08.049. Epub 2005 Dec 15. J Am Coll Cardiol. 2006. PMID: 16386671 Clinical Trial.
-
Long-term outcome of patients who received implantable cardioverter defibrillators for stable ventricular tachycardia.J Cardiovasc Electrophysiol. 2004 Jun;15(6):658-64. doi: 10.1046/j.1540-8167.2004.03344.x. J Cardiovasc Electrophysiol. 2004. PMID: 15175060
-
QRS duration does not predict occurrence of ventricular tachyarrhythmias in patients with implanted cardioverter-defibrillators.J Am Coll Cardiol. 2005 Jul 19;46(2):310-6. doi: 10.1016/j.jacc.2005.03.060. J Am Coll Cardiol. 2005. PMID: 16022960 Clinical Trial.
-
Implanted defibrillators and primary prevention of sudden cardiac death: where are we today?Int J Cardiol. 2005 Jan;98(1):15-20. doi: 10.1016/j.ijcard.2003.10.032. Int J Cardiol. 2005. PMID: 15676160 Review.
-
Primary and secondary prevention of sudden cardiac death: the role of the implantable cardioverter defibrillator.Rev Cardiovasc Med. 2001 Fall;2(4):197-205. Rev Cardiovasc Med. 2001. PMID: 12439369 Review.
Cited by
-
Impact of gender on heart failure presentation in non-obstructive hypertrophic cardiomyopathy.Heart Vessels. 2020 Feb;35(2):214-222. doi: 10.1007/s00380-019-01492-0. Epub 2019 Sep 3. Heart Vessels. 2020. PMID: 31482215
-
Gender differences in the pathophysiology, clinical presentation, and outcomes of ischemic heart failure.Curr Heart Fail Rep. 2012 Dec;9(4):267-76. doi: 10.1007/s11897-012-0107-7. Curr Heart Fail Rep. 2012. PMID: 22864856 Free PMC article. Review.
-
Roles and indications for use of implantable defibrillator and resynchronization therapy in the prevention of sudden cardiac death in heart failure.Heart Fail Rev. 2016 Jul;21(4):433-46. doi: 10.1007/s10741-016-9542-y. Heart Fail Rev. 2016. PMID: 26910804 Review.
-
Myocardial scar burden predicts survival benefit with implantable cardioverter defibrillator implantation in patients with severe ischaemic cardiomyopathy: influence of gender.Heart. 2014 Feb;100(3):206-13. doi: 10.1136/heartjnl-2013-304261. Epub 2013 Oct 31. Heart. 2014. PMID: 24186562 Free PMC article.
-
Underrepresentation of women in implantable cardioverter defibrillator trials.Am Heart J Plus. 2022 Mar 29;14:100120. doi: 10.1016/j.ahjo.2022.100120. eCollection 2022 Feb. Am Heart J Plus. 2022. PMID: 38560561 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous